AGP Executive Report
Last update: 11 hours agoClinical Breakthrough: CureGene says the first U.S. participant has been dosed in its Evategrel (CG-0255) pivotal trial, aiming for an NDA path for a new antiplatelet that could help patients who struggle with clopidogrel. AI Policy Clash: A U.S. debate is heating up over restrictions on access to advanced AI models, with export-control and security concerns driving the fight. Medical Tech in Focus: A Yale breast-imaging expert explains how mammography has evolved and how AI could change screening workflows. Aviation Safety: The FAA is turning to AI to reduce close calls between planes at U.S. airports. Defense Tech Testing: Army Reserve teams are running live counter-drone evaluations using systems like SMASH and Dronebuster 4. EV & Energy Capital: Investor attention keeps building around lithium mining and EV charging tech, with multiple market-facing updates. Space Security: SpaceX launched the 14th NRO spy-satellite mission, supporting the Golden Dome missile-defense backbone. Health Costs Spotlight: Alaska’s healthcare crisis is traced to the high price of hospital care, not just premiums. Global Talks: VP J.D. Vance heads to Switzerland to negotiate nuclear and Lebanon ceasefire details with Iran.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
